Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NSE - Delayed Quote INR

Valiant Laboratories Limited (VALIANTLAB.NS)

Compare
80.62
-7.00
(-7.99%)
At close: February 28 at 3:29:59 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Santosh Shantilal Vora Managing Director & Executive Director 1.2M -- 1994
Mr. Paresh Shashikant Shah CFO & Executive Director 1.5M -- 1960
Ms. Rachi Santosh Vora Executive Officer -- -- --
Ms. Prajakta Kantishwar Patil Company Secretary & Compliance Officer -- -- 1992
Mr. Nilesh Vinayak Patil Research & Development Head -- -- 1983
Mr. Jyotibhushan Singh Unit Head -- -- 1972
Meghana Shivpal Wasnik Head of R&D -- -- --
Mr. Chandrakant Mahadeo Mandhare Head Accounts & Finance -- -- 1978

Valiant Laboratories Limited

104, Udyog Kshetra
1st Floor Above Krishna Motors, Near D-mart Mulund Goregaon Link Road, Mulund West
Mumbai, 400080
India
91 22 4971 2001 https://valiantlabs.in
Sector: 
Healthcare
Full Time Employees: 
77

Description

Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India. Valiant Laboratories Limited is a subsidiary of Dhanvallabh Ventures LLP.

Corporate Governance

Valiant Laboratories Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events